Kerala Ayurveda Ltd.
Snapshot View

72.00 +0.05 ▲0.1%

06 October 2022, 04:01:00 PM
Volume: 3,397

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.keralaayurveda.biz
Market Cap 76.00 Cr.
Enterprise Value(EV) 143.06 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.15 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 62.86 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 1.91 Trailing Twelve Months Ending 2022-06
Price to Book Value 37.67 Calculated using Price: 72.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.06 Cr. 10,555,670 Shares
FaceValue 10
Company Profile
Kerala Ayurveda Ltd. (KAL) was founded on the banks of river Periyar at Aluva, Kochi, Kerala in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen in Ayurvedic system, a visionary and a mentor. Now, more than half a century later, his inspired creation epitomizes all that is modern and state-of-the-art in Ayurveda. A leading Ayurvedic company today, KAL is backed by advanced technology and highly qualified dedicated staff.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.07%
1 Week
+3.75%
1 Month
+1.41%
3 Month
+1.84%
6 Month
-10.39%
1 Year
+18.03%
2 Year
+35.72%
5 Year
-10.39%
10 Year
+67.05%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 862.54 38.72 43.39 93.90 -183.04
Return on Capital Employed (%) 2.39 5.38 8.35 9.15 8.91 8.88 7.64 9.27 -0.45
Return on Assets (%) -0.92 1.47 3.72 3.81 4.27 3.14 2.59 4.15 -4.47

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds -11 -10 -9 -6 7 8 4 8 3 6
Non Curr. Liab. 58 51 53 53 24 48 59 63 74 42
Curr. Liab. 13 23 25 24 48 45 28 31 34 60
Minority Int. 1 1 1 1 1 2 2 2 2 2
Equity & Liab. 61 64 71 73 81 103 92 103 114 110
Non Curr. Assets 51 55 57 59 59 61 64 67 67 73
Curr. Assets 9 9 14 14 22 42 28 33 44 37
Misc. Exp. not W/O 0 3 3
Total Assets 61 64 71 73 81 103 92 103 114 110

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 31 35 39 46 50 56 62 77 62 79
Other Income 0 1 0 1 0 0 1 0 0 0
Total Income 31 35 39 46 51 56 63 77 62 79
Total Expenditure -28 -32 -33 -39 -43 -48 -57 -69 -61 -71
PBIDT 3 4 6 8 7 8 5 7 1 8
Interest -1 -1 -2 -2 -1 -2 -3 -2 -6 -6
Depreciation -2 -1 -1 -2 -2 -2 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 0 2 -1
Exceptional Items 0 0 1 1
PAT 0 1 3 3 3 3 3 4 -5 1
Minority Interest 0 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit -1 1 2 3 3 3 2 4 -5 1
Adjusted EPS -1 1 2 3 3 3 2 4 -5 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 9 -8 0 0 6 4 -10 12 5 7
Cash Fr. Inv. -1 -4 -1 0 -3 -3 -3 -3 -4 -1
Cash Fr. Finan. -11 11 1 2 -3 0 17 -12 1 6
Net Change -3 0 -1 2 0 1 4 -2 2 12
Cash & Cash Eqvt 1 1 1 2 2 3 7 5 6 19

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 61.52 61.52 61.52 61.52 61.52 61.52 61.52 61.52 61.52
Public 38.48 38.48 38.48 38.48 38.48 38.48 38.48 38.48 38.48
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Announcements View Details >>

Mon, 03 Oct 2022
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance certificate under reg 74(5) of SEBI(DP) Regulations 2018 attached.
Sat, 01 Oct 2022
Closure of Trading Window
Closure of trading window notice attached.
Thu, 29 Sep 2022
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary/Compliance officer

Technical Scans View Details >>

Tue, 04 Oct 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Near 100 SMA Closing Near 100 SMA
Closing Near 200 SMA Closing Near 200 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Kerala Ayurveda Ltd.

What is Kerala Ayurveda share price?

Can I buy Kerala Ayurveda shares now?

What is the Market Cap of Kerala Ayurveda?

What are the key metrics to analyse Kerala Ayurveda?

What is the 52 Week High and Low of Kerala Ayurveda?

What is the trend of Kerala Ayurveda share price?